| Literature DB >> 10747086 |
S Siniossoglou1, M Lutzmann, H Santos-Rosa, K Leonard, S Mueller, U Aebi, E Hurt.
Abstract
The Nup84p complex consists of five nucleoporins (Nup84p, Nup85p, Nup120p, Nup145p-C, and Seh1p) and Sec13p, a bona fide subunit of the COPII coat complex. We show that a pool of green fluorescent protein-tagged Sec13p localizes to the nuclear pores in vivo, and identify sec13 mutant alleles that are synthetically lethal with nup85Delta and affect the localization of a green fluorescent protein-Nup49p reporter protein. In the electron microscope, sec13 mutants exhibit structural defects in nuclear pore complex (NPC) and nuclear envelope organization. For the assembly of the complex, Nup85p, Nup120p, and Nup145p-C are essential. A highly purified Nup84p complex was isolated from yeast under native conditions and its molecular mass was determined to be 375 kD by quantitative scanning transmission electron microscopy and analytical ultracentrifugation, consistent with a monomeric complex. Furthermore, the Nup84p complex exhibits a Y-shaped, triskelion-like morphology 25 nm in diameter in the transmission electron microscope. Thus, the Nup84p complex constitutes a paradigm of an NPC structural module with distinct composition, structure, and a role in nuclear mRNA export and NPC bio- genesis.Entities:
Mesh:
Substances:
Year: 2000 PMID: 10747086 PMCID: PMC2175103 DOI: 10.1083/jcb.149.1.41
Source DB: PubMed Journal: J Cell Biol ISSN: 0021-9525 Impact factor: 10.539
Yeast Strains
| Yeast strains | |
|---|---|
| RS453 |
|
| NUP120-ProtA |
|
| NUP84-ProtA |
|
| nup84− |
|
| nup85Δ |
|
| seh1− | MATa,ade2,his3,leu2,trp1,ura3,seh1::HIS3 |
| SEC13 shuffle |
|
| ProtA-NUP85 |
|
| NUP84-ProtA |
|
| ProtA-TEV-NUP85 |
|
| seh1(Δ248-288)-ProtA |
|
| SEC13-GFP |
|
| SEC13-GFP/nup133− |
|
| sec13-3 |
|
| SEC13-ProtA |
|
| SEC13/seh1− |
|
| SEC13/nup84− |
|
| SEC13/nup85Δ |
|
| sec13-34/nup85Δ |
|
| sec13-14/nup85Δ |
|
| SEH1-ProtA |
|
| sec13-3/NIC96-GFP | MATa,ade2,his3,leu2,trp1,ura3,sec13::HIS3,nic96::HIS3 |
| sec23-1 |
|
| NUP145-ProtA |
|
Figure 1A pool of Sec13p-GFP localizes to the nuclear pores. (a) The sec13 − /nup133 − double mutant complemented by either SEC13-GFP and NUP133 (sec13::HIS3) or by SEC13-GFP alone (nup133::HIS3) was analyzed by fluorescence microscopy (upper panel). In addition, Spo7p-GFP (Siniossoglou et al. 1998) and GFP-Nup49p were tested in the nup133 − cells (upper panel). For comparison, the seh1::HIS3 disruption mutant complemented by plasmid-borne SEH1-GFP was analyzed in the fluorescence microscope (lower panel). (b) The sec13 − /nup133 − double mutant expressing Sec13p-GFP was analyzed by indirect immunofluorescence microscopy using a monoclonal anti-Nsp1p antibody. It was also stained for DNA.
Nup84p Complex Assembly in Nucleoporin Mutants
| Strain background | Nup84p-ProtA associated proteins | Seh1p-ProtA associated proteins |
|---|---|---|
| nup84::HIS3 | Nup85p, Nup120p, Nup145Cp, Seh1p, Sec13p | Nup85p, Nup120p, Nup145Cp, Sec13p |
| nup120::HIS3 | − | Nup85p |
|
| ND | Nup85p |
| seh1::HIS3 | Nup85p, Nup120p, Nup145Cp, Sec13p | Nup84p, Nup85p, Nup120p, Nup145Cp, Sec13p |
|
| ND | Nup84p, Nup85p, Nup120p, Nup145Cp |
Assembly of the Nup84p complex in nucleoporin mutants. Nup84p-ProtA or Seh1p-ProtA were affinity-purified from nup84::HIS3, nup120::HIS3, seh1::HIS3, nup145ΔC, and sec13-34 strains. The components, which copurified, are listed in the table. ND, not determined.
Figure 5Purification of a native Nup84p complex. (a) TEV protease induced release of affinity-purified ProtA-TEV-Nup85p from IgG-Sepharose beads. Schematic representation of the ProtA-TEV-Nup85p fusion protein consisting of two IgG binding domains (ProtA), a 10 residue long spacer sequence, the 7 residue long TEV cleavage sequence (underlined) with the cleavage site (indicated by an arrow), followed by the Nup85p sequence. After TEV elution from the beads, a first and second eluate (E1 and E2) were obtained. Finally, a low pH eluate (HAc) was collected. All eluates were analyzed by SDS-PAGE and Western blotting using anti-Nup85p and anti-ProtA antibodies. The positions of the ProtA-TEV-Nup85p and the cleaved Nup85p, lacking the ProtA tag are indicated. (b) Gel filtration chromatography of the affinity-purified and TEV-released Nup84p complex. The eluates E1 and E2, which were combined and concentrated to yield the load fraction (L) were analyzed by FPLC Superose 6 column chromatography. 0.6-ml fractions were collected and 25 μl of fractions 1–27, E1 and E2, and the load (L, 5% of the injected material) were analyzed by SDS-PAGE and silverstaining. The six subunits containing Nup84p complex peak in fraction 9, the Nup85p-Seh1p heterodimer in fraction 15. Fractions 9 and 15 were also analyzed by Western blotting using anti-Nup85p, anti-Nup84p, anti-Seh1p, and anti-Sec13p antibodies, respectively. The positions of the components of the Nup84p complex are indicated. Heavy and light IgG chains are evident in fractions 15 and 16, and the TEV protease in fractions 19 and 20. The Superose 6 column was calibrated with several molecular weight marker proteins of 670, 440, 252, and 158 kD (Bio-Rad).